LEAVING OUR WEBSITE

You are now leaving our website.
Kindly note that this link is offered as a service and EVER is not responsible for any content published on the thirds-party website you are about to enter.

Cerebrolysin - General information
  • Home
  • Cerebrolysin®
    • About Cerebrolysin®
    • Safety
    • Mode of Action
    • Prescribing Information
    • Administration
    • FAQs
    • Download Area
  • Stroke
    • Disease
    • Clinical Efficacy
    • Administration
    • Expert Interviews
    • Rehabilitation
    • Trainings
    • Download Area
  • Dementia
    • Disease
    • Clinical Efficacy
    • Administration
    • Download Area
  • TBI
    • Disease
    • Clinical Efficacy
    • Administration
    • Expert Interviews
    • Download Area
  • News
  • Webinars
  • Links
  • Search
     

Welcome to
Cerebrolysin®

This website has been designed for Healthcare Professionals who would like to get additional information and support for the Cerebrolysin® therapy.

About
Cerebrolysin®

About
Stroke

About
Dementia

About
TBI

Frequent
News

Review about EVER Webinar ‘Get with the guidelines in post-stroke motor recovery’

Summary Report of Expert Panel Discussion

22.06.2022

Read more

Review about EVER Webinar 'Evidence-based neurorecovery after stroke and TBI'

Summary Report Webinar 2022 #1

03.06.2022

Read more

Products
  • Imprint
  • Disclaimer
  • Data Privacy
  • Terms of Use
  • Sitemap
  • Adverse Events
  • Contact

© 2022 EVER Neuro Pharma GmbH

To access the site for information on Cerebrolysin® please confirm that you are a healthcare professional.

No, I am not a healthcare professional